JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB109111

Anti-Cytokeratin 20 antibody [EPR1621(2)] - Cytoskeleton Marker

1

(5 Reviews)

|

(4 Publications)

Rabbit Recombinant Monoclonal Cytokeratin 20 antibody. Cytoskeleton marker. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 4 publications.

View Alternative Names

Cytokeratin-20, Keratin-20, Protein IT, CK-20, K20, KRT20

4 Images
Flow Cytometry (Intracellular) - Anti-Cytokeratin 20 antibody [EPR1621(2)] - Cytoskeleton Marker (AB109111)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-Cytokeratin 20 antibody [EPR1621(2)] - Cytoskeleton Marker (AB109111)

Flow Cytometry analysis of HT-29 (Human colorectal adenocarcinoma epithelial cell) cells labelling Cytokeratin 20 with Purified ab109111 at 1 : 20 dilution (10 µg/ml) (Red). Cells were fixed with 4% Paraformaldehyde and permeabilised with 90% Methanol. A Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) secondary antibody was used at 1 : 2000. Isotype control - Rabbit monoclonal IgG (Black). Unlabelled control - Cell without incubation with primary antibody and secondary antibody (Blue).

Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 20 antibody [EPR1621(2)] - Cytoskeleton Marker (AB109111)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 20 antibody [EPR1621(2)] - Cytoskeleton Marker (AB109111)

Immunocytochemistry analysis of HT-29 (Human colorectal adenocarcinoma epithelial cell) cells labeling Cytokeratin 20 with Purified ab109111 at 1 : 50 dilution (3.1 µg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1 : 200 (2.5 µg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1 : 1000 (2 µg/ml) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.

Flow Cytometry (Intracellular) - Anti-Cytokeratin 20 antibody [EPR1621(2)] - Cytoskeleton Marker (AB109111)
  • Flow Cyt (Intra)

Lab

Flow Cytometry (Intracellular) - Anti-Cytokeratin 20 antibody [EPR1621(2)] - Cytoskeleton Marker (AB109111)

This data was generated with the unpurified version of this antibody.

Intracellular Flow Cytometry analysis of SW480 (human colorectal adenocarcinoma) cells labeling Cytokeratin 20 with unpurified ab109111 at 1/20 dilution (10ug/ml) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluor® 488) (ab150077) (1/2000 dilution) was used as the secondary antibody. Rabbit monoclonal IgG (Black) (ab172730) was used as the isotype control, Cell without incubation with primary antibody and secondary antibody (Blue) were used as the unlabeled control.

Western blot - Anti-Cytokeratin 20 antibody [EPR1621(2)] - Cytoskeleton Marker (AB109111)
  • WB

Lab

Western blot - Anti-Cytokeratin 20 antibody [EPR1621(2)] - Cytoskeleton Marker (AB109111)

This data was generated with the unpurified version of this antibody.

False colour image of Western blot : Anti-Cytokeratin 20 antibody [EPR1621(2)] - Cytoskeleton Marker staining at 1/10000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab109111 was shown to bind specifically to Cytokeratin 20. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.

All lanes:

Western blot - Anti-Cytokeratin 20 antibody [EPR1621(2)] - Cytoskeleton Marker (ab109111) at 1/10000 dilution

Lane 1:

HT-29 cell lysate at 20 µg

Lane 2:

Daudi cell lysate at 20 µg

Lane 3:

MCF7 cell lysate at 20 µg

Predicted band size: 48 kDa

Observed band size: 45 kDa,45-50 kDa

false

  • Carrier free

    Anti-Cytokeratin 20 antibody [EPR1621(2)] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR1621(2)

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

WB, Flow Cyt (Intra), ICC/IF

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000", "WB-species-notes": "<p>For unpurified use at 1/10000 - 1/50000.</p>", "IHCP-species-checked": "notRecommended", "IHCP-species-dilution-info": "", "IHCP-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/50 - 1/100", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/20", "FlowCytIntra-species-notes": "<p></p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle|Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Cytokeratin 20 often known as CK20 KRT20 or keratin 20 is a type of intermediate filament protein that is highly specific to epithelial cells. This cytoskeletal protein has a molecular weight of approximately 46.5 kDa. Cytokeratin 20 is primarily found in the gastric and intestinal epithelium urothelium and Merkel cells. Its function as part of the cytoskeleton provides structural integrity and strength to cells maintaining their shape and resilience against mechanical stress.
Biological function summary

Cytokeratin 20 is essential in cellular differentiation and maintenance within epithelial tissues. It plays an important role in the structural framework of epithelial cells by integrating into the cytoskeletal network which includes other keratins. Typically cytokeratin 20 forms heterodimers with keratin 8 contributing to the assembly of intermediate filaments. These interactions maintain cell stability and are involved in cellular processes such as migration and proliferation.

Pathways

Cytokeratin 20 participates in the framework of intermediate filament signaling influencing cell motility and secretion in epithelial tissues. It contributes mainly to the keratinization pathway which is critical in forming a protective barrier in epithelial cells. Additionally it is related to cell adhesion and signalling pathways that are important for tissue integrity. Connections with keratin 8 and other cytoskeletal proteins facilitate signal transduction processes necessary for epithelial homeostasis and response to injury.

Cytokeratin 20 serves as a valuable marker for identifying specific cancer types particularly colorectal adenocarcinomas and Merkel cell carcinoma. The presence of cytokeratin 20 is often used in immunohistochemistry for cancer diagnosis and prognosis. Its expression pattern is notably distinct helping differentiate between various adenocarcinomas. In colorectal cancer it shows a unique interaction with proteins like keratin 8 supporting the tumor's structural environment and influencing tumorigenesis and metastasis processes.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Plays a significant role in maintaining keratin filament organization in intestinal epithelia. When phosphorylated, plays a role in the secretion of mucin in the small intestine (By similarity).
See full target information KRT20

Publications (4)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 16:6397 PubMed40640184

2025

PIP4K2C inhibition reverses autophagic flux impairment induced by SARS-CoV-2.

Applications

Unspecified application

Species

Unspecified reactive species

Marwah Karim,Manjari Mishra,Chieh-Wen Lo,Sirle Saul,Halise Busra Cagirici,Manon Gourdelier,Luca Ghita,Amrita Ojha,Do Hoang Nhu Tran,Aditi Agrawal,Connor McGraw,Michael P East,Karen Anbro Gammeltoft,Malaya Kumar Sahoo,Nancie A Mooney,Gary L Johnson,Soumita Das,Pieter Leyssen,Johan Neyts,Winston Chiu,Courtney A Cohen,Jens Bukh,Judith Gottwein,John M Dye,Norma Neff,Peter K Jackson,Benjamin A Pinsky,Tuomo Laitinen,Tatu Pantsar,Antti Poso,Fabio Zanini,Steven De Jonghe,Christopher R M Asquith,Shirit Einav

Advanced science (Weinheim, Baden-Wurttemberg, Germany) 12:e2406935 PubMed39582289

2024

mA Reader PRRC2A Promotes Colorectal Cancer Progression via CK1ε-Mediated Activation of WNT and YAP Signaling Pathways.

Applications

Unspecified application

Species

Unspecified reactive species

Xi Wu,Shiyang Wang,Yuwei Pan,Mengzhen Li,Manyu Song,Hanfu Zhang,Min Deng,Xu Yang,Jiuzhi Xu,Shuo Zhang,Jinhua Zhang,Fengchao Wang,Maksim V Plikus,Cong Lv,Lu Yu,Zhengquan Yu

Bioengineering & translational medicine 8:e10327 PubMed36684067

2023

Extracellular matrix bioink boosts stemness and facilitates transplantation of intestinal organoids as a biosafe Matrigel alternative.

Applications

Unspecified application

Species

Unspecified reactive species

Zi-Yan Xu,Jin-Jian Huang,Ye Liu,Can-Wen Chen,Gui-Wen Qu,Ge-Fei Wang,Yun Zhao,Xiu-Wen Wu,Jian-An Ren

Molecular medicine reports 24: PubMed34396431

2021

Chemosensitivity analysis and study of gene resistance on tumors and cancer stem cell isolates from patients with colorectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Elsa N Garza-Treviño,Herminia G Martínez-Rodríguez,Paulina Delgado-González,Orlando Solís-Coronado,Rocio Ortíz-Lopez,Adolfo Soto-Domínguez,Víctor M Treviño,Gerardo R Padilla-Rivas,Jose F Islas-Cisneros,Adriana G Quiroz-Reyes,Salvador L Said-Fernández
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com